Quantcast

Latest Astellas Pharma US Inc. Stories

2009-09-21 09:03:00

DEERFIELD, Ill., Sept. 21 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), in partnership with the National Science Teachers Association (NSTA), is pleased to welcome its second-year class of Chicago-area science teachers to participate in the 2009 NSTA New Science Teacher Academy. The national, year-long program connects new science teachers to a range of tools and resources, while providing the support needed to build a strong foundation for science in their classrooms. The 2009...

2009-08-17 12:44:00

DEERFIELD, Ill., Aug. 17 /PRNewswire/ -- Chicago Mayor Richard M. Daley honored Astellas Pharma US, Inc. and two other Chicagoland companies on Aug. 14 at a ceremony in downtown Chicago with an award for their exemplary learning and development practices. The award and the event are sponsored each year by WorkforceChicago, which recognizes Chicagoland companies with exceptional learning and development programs. "Learning is the oxygen that breathes life into every successful...

2009-08-12 18:35:00

DEERFIELD, Ill., Aug. 12 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") announced today an update regarding the status of the request for emergency relief and preliminary injunction from the U.S. Food and Drug Administration's (FDA) decision regarding its Citizen Petition. The company's requests have been denied by the U.S. District Court in Washington, D.C. The company is disappointed in the court's decision and is currently evaluating its next course of action. The Citizen...

2009-08-11 14:19:00

DEERFIELD, Ill., Aug. 11 /PRNewswire/ -- In a ceremony recognizing "Chicago's 101 Best and Brightest Companies to Work For," Astellas Pharma US, Inc. won an Elite award for employee engagement and commitment by the National Association for Business Resources (NABR). Astellas scored high in all 10 categories and was specifically recognized for the high level of employees' engagement and pride in the company. "At Astellas, we understand that investment in our employees is vital to...

2009-08-10 22:52:00

DEERFIELD, Ill., Aug. 10 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") announced today that the U.S. Food and Drug Administration (FDA) has substantially denied the company's Citizen Petition to ensure the safe and effective use of immunosuppressants (also called anti-rejection medications) used to prevent rejection in organ transplant patients. In their petition, Astellas requested that the FDA take additional measures to protect transplant recipients, a unique and vulnerable...

2009-08-10 18:45:00

NASDAQ: CRME TSX: COM VANCOUVER and DEERFIELD, IL, Aug. 10 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) and its co-development partner Astellas Pharma US, Inc. ("Astellas") announced today that Astellas will undertake a single confirmatory additional Phase 3 clinical trial of KYNAPID(TM) (vernakalant hydrochloride) Injection for rapid conversion of atrial fibrillation to sinus rhythm. The trial, to be called ACT 5, is expected to begin enrolling patients by...

2009-08-03 07:52:00

SAN DIEGO and DEERFIELD, Ill., August 3 /PRNewswire/ -- Zogenix, Inc. ("Zogenix"), a privately held pharmaceutical company and Astellas Pharma US, Inc. ("Astellas"), announced today their exclusive co-promotion agreement for Sumavel DosePro (sumatriptan injection) needle-free delivery system. Sumavel DosePro received FDA approval in July 2009 and is a first-of-its-kind needle-free delivery system for subcutaneous sumatriptan, a treatment that provides migraine relief within 10 minutes for...

2009-06-02 11:37:00

DEERFIELD, Ill., June 2 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") recently hired Dan Dunham as the vice president of compliance. Dunham will be responsible for governance of the compliance program to ensure Astellas' observance of federal and state health care program requirements and regulations. "We are very pleased to add Dan to our senior management team to provide strategic direction and leadership for the compliance department," said Seigo Kashii, president and CEO of...

2009-05-28 08:30:00

DEERFIELD, Ill., May 28 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") recently hired Walt Johnston as vice president of marketing. Reporting directly to Patrick Shea, senior vice president of marketing & sales, Johnston will be responsible for leading all strategic marketing activities for on market and development products for the United States business. "Walt is a driven high performer who truly understands Astellas' core values. We are excited to add him to our management...

2009-05-28 08:00:00

DEERFIELD, Ill., May 28 /PRNewswire/ -- The Food and Drug Administration (FDA) has granted Astellas Pharma US, Inc. approval for the use of Prograf(R) (tacrolimus) in conjunction with mycophenolate mofetil (MMF) for the prevention of organ rejection in kidney transplant recipients. Prograf is a cornerstone therapy for preventing transplant rejection in liver, kidney and heart transplant recipients. The approval came on May 19, 2009 in response to a Supplemental New Drug Application (sNDA)...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.